Risk of severe coronavirus disease 2019 despite vaccination in patients requiring treatment with immune-suppressive drugs: A nationwide cohort study of US Veterans.

Sonia T AnandAustin D VoJennifer LaMary BrophyNhan V DoNathanael R FillmoreWestyn Branch-EllimanPaul A Monach

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2023)

The risk of severe COVID-19 despite vaccination is substantial in patients taking immune-suppressive drugs, more so in patients with SOT than in patients with inflammatory diseases. Age and severe comorbidities contribute to risk, as in the general population. Oral antivirals were very beneficial but not widely used.

Keyphrases

coronavirus disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
sars cov
early onset
oxidative stress
drug induced
patient reported outcomes
patient reported
respiratory syndrome coronavirus